The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit is kicking off in Washington, D.C.
Now in its 12th year, the event brings together patient advocates, academia, regulators, and the biotechnology industry for a few days of sharing best practices and networking.
This year’s theme, “The Importance of the Patient Voice,” aims to “strengthen the understanding of the patients we serve, raise awareness and understanding of diseases, and advance patient-focused public policies,” says BIO.
BIO’s Patient Advocacy Committee – recently renamed the Patient Centricity and Advocacy Committee – “remains committed to paving the way for Patient Advocacy Organizations and biotech peers alike, especially those who are just starting to build their advocacy functions, so they too can more effectively connect with their patient communities ensuring the important patient insights and patient voices are reflected in clinical research and drug development, as well as legislative and policy changes,” says Eric Dube, President and CEO of Travere Therapeutics and Chair of the Committee.
What we’re watching at PHAS 2023
What we’re watching at the 2023 Patient Advocacy Summit: